BNP Paribas Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $616M | Buy |
4,423,414
+751,413
| +20% | +$105M | 0.72% | 19 |
|
|
2025
Q4 | $451M | Buy |
3,672,001
+1,981,714
| +117% | +$241M | 0.52% | 28 |
|
|
2025
Q3 | $187M | Sell |
1,690,287
-707,534
| -30% | -$80.4M | 0.48% | 31 |
|
|
2025
Q2 | $266M | Sell |
2,397,821
-354,665
| -13% | -$37.7M | 0.65% | 21 |
|
|
2025
Q1 | $308M | Buy |
2,752,486
+940,873
| +52% | +$97.1M | 0.83% | 18 |
|
|
2024
Q4 | $167M | Buy |
1,811,613
+1,047,093
| +137% | +$94.3M | 0.41% | 44 |
|
|
2024
Q3 | $64.1M | Buy |
764,520
+211,493
| +38% | +$16.1M | 0.16% | 144 |
|
|
2024
Q2 | $37.9M | Sell |
553,027
-113,310
| -17% | -$7.56M | 0.1% | 211 |
|
|
2024
Q1 | $48.8M | Sell |
666,337
-697,300
| -51% | -$53.6M | 0.13% | 188 |
|
|
2023
Q4 | $110M | Buy |
1,363,637
+384,516
| +39% | +$29.9M | 0.31% | 78 |
|
|
2023
Q3 | $73.4M | Buy |
979,121
+23,412
| +2% | +$1.8M | 0.22% | 113 |
|
|
2023
Q2 | $73.7M | Sell |
955,709
-126,241
| -12% | -$10.1M | 0.23% | 110 |
|
|
2023
Q1 | $89.8M | Buy |
1,081,950
+156,538
| +17% | +$13M | 0.31% | 73 |
|
|
2022
Q4 | $79.4M | Sell |
925,412
-717,705
| -44% | -$56.8M | 0.28% | 89 |
|
|
2022
Q3 | $101M | Buy |
1,643,117
+8,598
| +0.5% | +$542K | 0.4% | 53 |
|
|
2022
Q2 | $101M | Sell |
1,634,519
-1,553
| -0.1% | -$96.2K | 0.39% | 53 |
|
|
2022
Q1 | $97.3M | Buy |
1,636,072
+257,337
| +19% | +$16.4M | 0.34% | 61 |
|
|
2021
Q4 | $100M | Sell |
1,378,735
-334,360
| -20% | -$23M | 0.33% | 68 |
|
|
2021
Q3 | $120M | Sell |
1,713,095
-311,819
| -15% | -$21.9M | 0.44% | 51 |
|
|
2021
Q2 | $139M | Buy |
2,024,914
+324,369
| +19% | +$21.7M | 0.5% | 42 |
|
|
2021
Q1 | $110M | Buy |
1,700,545
+73,748
| +5% | +$4.76M | 0.45% | 47 |
|
|
2020
Q4 | $94.8M | Sell |
1,626,797
-111,468
| -6% | -$6.73M | 0.44% | 45 |
|
|
2020
Q3 | $110M | Buy |
1,738,265
+424,539
| +32% | +$29.4M | 0.62% | 29 |
|
|
2020
Q2 | $101M | Buy |
1,313,726
+428,556
| +48% | +$32.8M | 0.68% | 21 |
|
|
2020
Q1 | $66.2M | Buy |
885,170
+165,533
| +23% | +$11.4M | 0.56% | 28 |
|
|
2019
Q4 | $46.8M | Buy |
719,637
+56,842
| +9% | +$3.7M | 0.32% | 82 |
|
|
2019
Q3 | $42M | Sell |
662,795
-193,184
| -23% | -$12.6M | 0.32% | 76 |
|
|
2019
Q2 | $57.8M | Sell |
855,979
-33,531
| -4% | -$2.21M | 0.47% | 40 |
|
|
2019
Q1 | $57.8M | Sell |
889,510
-26,277
| -3% | -$1.75M | 0.48% | 34 |
|
|
2018
Q4 | $56.7M | Sell |
915,787
-72,182
| -7% | -$5.05M | 0.52% | 31 |
|
|
2018
Q3 | $76.3M | Sell |
987,969
-123,842
| -11% | -$9.35M | 0.59% | 25 |
|
|
2018
Q2 | $78.8M | Buy |
1,111,811
+250,160
| +29% | +$17.7M | 0.66% | 15 |
|
|
2018
Q1 | $65M | Buy |
861,651
+530,464
| +160% | +$42.2M | 0.55% | 22 |
|
|
2017
Q4 | $23.7M | Buy |
331,187
+167,048
| +102% | +$12.7M | 0.2% | 126 |
|
|
2017
Q3 | $13.3M | Sell |
164,139
-6,257
| -4% | -$478K | 0.11% | 241 |
|
|
2017
Q2 | $12.1M | Sell |
170,396
-19,035
| -10% | -$1.27M | 0.11% | 262 |
|
|
2017
Q1 | $12.9M | Sell |
189,431
-525,064
| -73% | -$36.9M | 0.12% | 230 |
|
|
2016
Q4 | $51.2M | Buy |
714,495
+526,864
| +281% | +$39.2M | 0.49% | 41 |
|
|
2016
Q3 | $14.8M | Sell |
187,631
-568,409
| -75% | -$46.2M | 0.13% | 223 |
|
|
2016
Q2 | $63.1M | Buy |
756,040
+282,862
| +60% | +$25.1M | 0.53% | 35 |
|
|
2016
Q1 | $43.5M | Sell |
473,178
-22,620
| -5% | -$2.04M | 0.37% | 62 |
|
|
2015
Q4 | $50.2M | Sell |
495,798
-20,940
| -4% | -$2.18M | 0.43% | 48 |
|
|
2015
Q3 | $50.7M | Sell |
516,738
-12,717
| -2% | -$1.41M | 0.44% | 38 |
|
|
2015
Q2 | $62M | Sell |
529,455
-431,372
| -45% | -$47.1M | 0.5% | 32 |
|
|
2015
Q1 | $94.3M | Sell |
960,827
-374,481
| -28% | -$38M | 0.72% | 13 |
|
|
2014
Q4 | $126M | Sell |
1,335,308
-259,769
| -16% | -$26.9M | 1.01% | 4 |
|
|
2014
Q3 | $170M | Sell |
1,595,077
-363,602
| -19% | -$35.6M | 1.38% | 3 |
|
|
2014
Q2 | $162M | Sell |
1,958,679
-338,668
| -15% | -$26.4M | 1.26% | 3 |
|
|
2014
Q1 | $163M | Sell |
2,297,347
-59,500
| -3% | -$4.67M | 1.23% | 5 |
|
|
2013
Q4 | $177M | Buy |
2,356,847
+1,088,733
| +86% | +$75.8M | 1.33% | 4 |
|
|
2013
Q3 | $79.7M | Sell |
1,268,114
-93,635
| -7% | -$5.6M | 0.6% | 37 |
|
|
2013
Q2 | $69.7M | Buy |
+1,361,749
| New | +$71M | 0.52% | 47 |
|
Other funds holding GILD
VCM
VPM
BNP Paribas Asset Management's GILD Position: Q1 2026 in Review
BNP Paribas Asset Management increased its Gilead Sciences (GILD) stake by 20% in Q1 2026, buying an estimated $105M and bringing the position to 4,423,414 shares worth $616M. The position accounts for 0.72% of the portfolio, ranked #19.
BNP Paribas Asset Management first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- BNP Paribas Asset Management held 4,423,414 shares of Gilead Sciences worth $616M as of Q1 2026.
- BNP Paribas Asset Management bought 751,413 Gilead Sciences shares in Q1 2026, an estimated $105M.
- Gilead Sciences made up 0.72% of BNP Paribas Asset Management's portfolio in Q1 2026, its #19 holding.
- BNP Paribas Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.